Close

UPDATE: JPMorgan Assumes Lumentum (LITE) at Neutral

Go back to UPDATE: JPMorgan Assumes Lumentum (LITE) at Neutral

Lumentum (LITE) PT Lowered to $90 at Craig-Hallum

May 13, 2021 9:15 AM EDT

Craig-Hallum analyst Richard Shannon lowered the price target on Lumentum (NASDAQ: LITE) to $90.00 (from $120.00) while maintaining a Buy rating.... More

Lumentum (LITE) PT Lowered to $90 at Northland Capital Markets

May 13, 2021 8:39 AM EDT

Northland Capital Markets analyst Tim Savageaux lowered the price target on Lumentum (NASDAQ: LITE) to $90.00 (from $130.00) while maintaining a Outperform rating.... More

Lumentum (LITE) PT Lowered to $90 at Jefferies for 3 Reasons

May 13, 2021 8:38 AM EDT

Jefferies analyst George Notter lowered the price target on Lumentum (NASDAQ: LITE) to $90.00 (from $115.00) after the earnings call revealed that 3D Sensing business economics are not as positive as previously believed resulting in three problems:
1) The company is losing more share than... More

Lumentum (LITE) PT Lowered to $87 at Needham & Company

May 13, 2021 6:45 AM EDT

Needham & Company analyst Alex Henderson lowered the price target on Lumentum (NASDAQ: LITE) to $87.00 (from $123.00) while maintaining a Buy rating.

The analyst commented, "Lumentum's print and guidance has unwound a lot of Revenue and earnings momentum, which in turn inhibits the valuation argument. From... More

UPDATE: Morgan Stanley Downgrades Lumentum (LITE) to Equalweight

May 13, 2021 2:16 AM EDT

(Updated - May 13, 2021 5:05 AM EDT)

Morgan Stanley analyst Meta Marshall downgraded Lumentum (NASDAQ: LITE) from Overweight to Equalweight with a price target of $81.00 (from $105.00).

THe analyst comments "LITE reported in-line FQ3 (incl def rev from delayed 5G deployments in... More

Lumentum (LITE) PT Lowered to $87 at Stifel

May 12, 2021 5:54 PM EDT

Stifel analyst John Marchetti lowered the price target on Lumentum (NASDAQ: LITE) to $87.00 (from $98.00) while maintaining a Hold rating.

... More

Lumentum (LITE) PT Lowered to $90 at Susquehanna

May 12, 2021 4:59 PM EDT

Susquehanna analyst Christopher Rolland lowered the price target on Lumentum (NASDAQ: LITE) to $90.00 (from $120.00) while maintaining a Positive rating.

... More

Pre-Open Stock Movers 05/12: (LHDX) (UPST) (EYES) Higher; (ARRY) (CURI) (LMND) Lower (more...)

May 12, 2021 9:26 AM EDT

Today's Pre-Open Movers:

Lucira Health, Inc. (Nasdaq: LHDX) 40.9% HIGHER; announced that its LUCIRA CHECK IT COVID-19 test kit is now available on Amazon.com in the US. Each LUCIRA CHECK IT test kit provides a PCR quality test result at home in 30 minutes or less. After testing, users can also receive a free, text based digital LUCI PASS verified test result on their... More

Lumentum Holdings (LITE) Reports In-Line Q3 EPS, Revenues Miss; Offers 4Q EPS/Revenues Guidance Below Consensus

May 12, 2021 7:34 AM EDT

Lumentum Holdings (NASDAQ: LITE) reported Q3 EPS of $1.40, in-line with the analyst estimate of $1.40. Revenue for the quarter came in at $419.5 million versus the consensus estimate of $433.49 million.

"The strong year on year margin improvements in our third quarter results highlight a product portfolio increasingly rich in new and differentiated products that are aligned with multi-year favorable market trends and the impact of continuous improvement in our... More